
Clearmind Medicine fell 95.9% from $110.76 to $4.53, behind the S&P 500's +13.3%. Its worst day was May 19 (−37.8%), and its low came Oct 1 at $0.72.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-380.00 was reported on $0.00 revenue.
−3.0% · S&P 500 +1.2%
EPS of $-265.60 was reported on $0.00 revenue.
−5.9% · S&P 500 −0.6%
Story events cover the past 12 months · Times ET
EPS of $-54.24 was reported on $0.00 revenue.
−6.8% · S&P 500 −0.6%
EPS of $-5.60 was reported on $0.00 revenue.
−1.5% · S&P 500 +0.9%
Clearmind Medicine closed at its lowest level of the year, 99.4% below where the year started.
−11.1% · S&P 500 +0.2%
Where it ended: a close of $4.53 on Nov 13, 2026. Up next: Q4 2026 earnings on Jan 19, 2027.
Nothing in the past 12 months.
All CMND analyst actionsNothing in the past 12 months.
All CMND dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CMND and SPY from Benzinga historical bars. Not investment advice.